Immunophotonics

Developer of a proprietary carbohydrate polymer designed to transform tumor ablation into hypnotherapy for cancer. The company's compound is intratumorally injected after a tumor ablation, utilizing t...

Healthcare

Saint Louis, MO, United States

Founded 2008

19 employees

Website

Valuation

Share Price

N/A

Total Raised

$93.9M

Last Round

N/A

Investors

+18 other investors

View all 18 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Immunophotonics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required